(PDF) Oral Anticoagulants for Prevention of Stroke in

Oral Anticoagulants for Prevention of Stroke in Atrial Fibrillation: Systematic Review, Network Meta-Analysis, and Cost Effectiveness Analysis

British Medical Journal - United Kingdom

doi 10.1136/bmj.k2295

Full Text

Abstract

Available in full text

Categories

Date

May 23, 2018

Authors

Unknown

Publisher

BMJ

Related search

Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation

Circulation. Cardiovascular quality and outcomes

Cardiovascular Medicine

English

PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial Fibrillation

Value in Health

Occupational Health

English

Cost-Effectiveness of New Oral Anticoagulants for Patients With Atrial Fibrillation – A Decision Analysis

Value in Health

Occupational Health

English

Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation

Circulation. Cardiovascular quality and outcomes

Cardiovascular Medicine

English

Real-World Adherence to Oral Anticoagulants in Atrial Fibrillation Patients: A Study Protocol for a Systematic Review and Meta-Analysis

English

Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis of the Literature

Cardiovascular Medicine

English

Treatments for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis and Indirect Comparisons Versus Dabigatran Etexilate

Thrombosis and Haemostasis

English

Cost-Effectiveness Analysis of Apixaban Against Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation in Japan

Clinical Therapeutics

English

Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients

Value in Health

Occupational Health

English